Literature DB >> 28552478

Allometric size: The scientific theory and extension to normal fat mass.

Nick H G Holford1, Brian J Anderson2.   

Abstract

Keywords:  Dosing; Fat free mass; Lean body weight; Normal fat mass; Obesity; Pharmacokinetics; Systems pharmacology; Theory based allometry

Mesh：

Substances：

Year:  2017        PMID： 28552478     DOI： 10.1016/j.ejps.2017.05.056

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN： 0928-0987            Impact factor:   4.384


× No keyword cloud information.
  31 in total

1.  How long will treatment guidelines for TB continue to overlook variability in drug exposure?

Authors:  Morris Muliaditan; Oscar Della Pasqua
Journal:  J Antimicrob Chemother       Date:  2019-11-01       Impact factor: 5.790

2.  A pharmacological rationale for improved everolimus dosing in oncology and transplant patients.

Authors:  R Ter Heine; N P van Erp; H J Guchelaar; J W de Fijter; M E J Reinders; C M van Herpen; D M Burger; D J A R Moes
Journal:  Br J Clin Pharmacol       Date:  2018-05-06       Impact factor: 4.335

3.  CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study.

Authors:  Jeffrey R Strawn; Ethan A Poweleit; Laura B Ramsey
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-02-28       Impact factor: 2.576

4.  A Population WB-PBPK Model of Colistin and its Prodrug CMS in Pigs: Focus on the Renal Distribution and Excretion.

Authors:  Alexis Viel; Jérôme Henri; Salim Bouchène; Julian Laroche; Jean-Guy Rolland; Jacqueline Manceau; Michel Laurentie; William Couet; Nicolas Grégoire
Journal:  Pharm Res       Date:  2018-03-12       Impact factor: 4.200

5.  The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults.

Authors:  Didi Bury; Rob Ter Heine; Ewoudt M W van de Garde; Marten R Nijziel; Rene J Grouls; Maarten J Deenen
Journal:  Eur J Clin Pharmacol       Date:  2019-03-15       Impact factor: 2.953

6.  Differences in the Pharmacokinetics of Gentamicin between Oncology and Nononcology Pediatric Patients.

Authors:  C C Llanos-Paez; C E Staatz; R Lawson; S Hennig
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

7.  Modelling pharmacokinetics and pharmacodynamics of the selective S1P1 receptor modulator cenerimod in healthy subjects and systemic lupus erythematosus patients.

Authors:  Dominik Lott; Pierre-Eric Juif; Jasper Dingemanse; Andreas Krause
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

8.  Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing.

Authors:  Eline W Muilwijk; Dylan W de Lange; Jeroen A Schouten; Roeland E Wasmann; Rob Ter Heine; David M Burger; Angela Colbers; Pieter J Haas; Paul E Verweij; Peter Pickkers; Roger J Brüggemann
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

9.  Prospective Cohort Study of Micafungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-abdominal Infections.

Authors:  Nicolas Garbez; Litaty Mbatchi; Steven C Wallis; Laurent Muller; Jeffrey Lipman; Jason A Roberts; Jean-Yves Lefrant; Claire Roger
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

10.  An artificial neural network-pharmacokinetic model and its interpretation using Shapley additive explanations.

Authors:  Chika Ogami; Yasuhiro Tsuji; Hiroto Seki; Hideaki Kawano; Hideto To; Yoshiaki Matsumoto; Hiroyuki Hosono
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.